Global and China Human Vaccine Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose. 

    This report elaborates on the current development of the Human Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Bharat Biotech

    • Sanofi

    • Merck

    • AstraZeneca

    • Bavarian Nordic

    • Baxter

    • GlaxoSmithKline

    • Pfizer

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Conjugate

    • Recombinant

    • Inactivated

    • Combination

    • Attenuated

    • Others

    Application:

    • Pediatrics

    • Adolescents

    • Adults

    • Geriatrics

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Human Vaccine Industry Overview

      • 1.1.1 Human Vaccine Market Scope and Market Segments

      • 1.1.2 Human Vaccine Industry Characteristics

      • 1.1.3 Global and China Human Vaccine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Human Vaccine Production Value and Growth Rate (2017-2028)

    • 1.2 Global Human Vaccine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Conjugate

      • 1.2.2 Recombinant

      • 1.2.3 Inactivated

      • 1.2.4 Combination

      • 1.2.5 Attenuated

      • 1.2.6 Others

    • 1.3 Global Human Vaccine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Pediatrics

      • 1.3.2 Adolescents

      • 1.3.3 Adults

      • 1.3.4 Geriatrics

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Human Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Human Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Human Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Human Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Human Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Human Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Human Vaccine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Human Vaccine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Human Vaccine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Human Vaccine Industry Porter's Five Forces Model Analysis

      • 2.2.3 Human Vaccine Industry PEST Analysis

    • 2.3 Human Vaccine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Human Vaccine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Human Vaccine Industry

    Chapter 3 Global and China Human Vaccine Market, by Manufacturer

    • 3.1 Global and China Human Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Human Vaccine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Human Vaccine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Human Vaccine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Human Vaccine Market Top 3 Players

    Chapter 4 Global and China Human Vaccine Market, by Type (2017-2028)

    • 4.1 Human Vaccine Market Trend, by Type

    • 4.2 Global Human Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Human Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Human Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Human Vaccine Price Trend, by Type (2017-2028)

    • 4.3 China Human Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Human Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Human Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Human Vaccine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Human Vaccine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Human Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Human Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Human Vaccine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Human Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Human Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Human Vaccine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Human Vaccine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Human Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Human Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Human Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Human Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Human Vaccine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Human Vaccine Market Analysis

    • 7.1 North America Human Vaccine Market, by Type

    • 7.2 North America Human Vaccine Market, by Application

    • 7.3 North America Human Vaccine Market Analysis and Forecast, by Country

      • 7.3.1 United States Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Human Vaccine Market Analysis

    • 8.1 Europe Human Vaccine Market, by Type

    • 8.2 Europe Human Vaccine Market, by Application

    • 8.3 Europe Human Vaccine Market Analysis and Forecast, by Country

      • 8.3.1 Germany Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Human Vaccine Market Analysis

    • 9.1 APAC Human Vaccine Market, by Type

    • 9.2 APAC Human Vaccine Market, by Application

    • 9.3 APAC Human Vaccine Market Analysis and Forecast, by Country

      • 9.3.1 China Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Human Vaccine Market Analysis

    • 10.1 Latin America, Middle East and Africa Human Vaccine Market, by Type

    • 10.2 Latin America, Middle East and Africa Human Vaccine Market, by Application

    • 10.3 Latin America, Middle East and Africa Human Vaccine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Human Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Human Vaccine Company Profiles

      • 11.1 Bharat Biotech

        • 11.1.1 Bharat Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Bharat Biotech Human Vaccine Product Profiles, Application and Specification

        • 11.1.3 Bharat Biotech Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Sanofi

        • 11.2.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Sanofi Human Vaccine Product Profiles, Application and Specification

        • 11.2.3 Sanofi Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Merck

        • 11.3.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Merck Human Vaccine Product Profiles, Application and Specification

        • 11.3.3 Merck Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 AstraZeneca

        • 11.4.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 AstraZeneca Human Vaccine Product Profiles, Application and Specification

        • 11.4.3 AstraZeneca Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Bavarian Nordic

        • 11.5.1 Bavarian Nordic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Bavarian Nordic Human Vaccine Product Profiles, Application and Specification

        • 11.5.3 Bavarian Nordic Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Baxter

        • 11.6.1 Baxter Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Baxter Human Vaccine Product Profiles, Application and Specification

        • 11.6.3 Baxter Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 GlaxoSmithKline

        • 11.7.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 GlaxoSmithKline Human Vaccine Product Profiles, Application and Specification

        • 11.7.3 GlaxoSmithKline Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Pfizer

        • 11.8.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Pfizer Human Vaccine Product Profiles, Application and Specification

        • 11.8.3 Pfizer Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Human Vaccine Industry Investment Prospect and Risk Assessment

    • 12.1 Human Vaccine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Human Vaccine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Global Human Vaccine Production Value and Growth Rate (2017-2028)

    • Figure China Human Vaccine Production Value and Growth Rate (2017-2028)

    • Figure Global Human Vaccine Market Size and Growth Rate of Conjugate (2017-2028)

    • Figure Global Human Vaccine Market Size and Growth Rate of Recombinant (2017-2028)

    • Figure Global Human Vaccine Market Size and Growth Rate of Inactivated (2017-2028)

    • Figure Global Human Vaccine Market Size and Growth Rate of Combination (2017-2028)

    • Figure Global Human Vaccine Market Size and Growth Rate of Attenuated (2017-2028)

    • Figure Global Human Vaccine Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Human Vaccine Market Size and Growth Rate of Pediatrics (2017-2028)

    • Figure Global Human Vaccine Market Size and Growth Rate of Adolescents (2017-2028)

    • Figure Global Human Vaccine Market Size and Growth Rate of Adults (2017-2028)

    • Figure Global Human Vaccine Market Size and Growth Rate of Geriatrics (2017-2028)

    • Figure North America Human Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Human Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Human Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Human Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Human Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Human Vaccine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Human Vaccine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Human Vaccine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Human Vaccine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Human Vaccine Market Share, by Manufacturer in 2021

    • Figure Global and China Human Vaccine Market Share, by Manufacturer in 2022

    • Table Global Human Vaccine Sales Volume, by Type (2017-2028)

    • Table Global Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Global Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Global Human Vaccine Sales Value, by Type (2017-2028)

    • Table Global Human Vaccine Sales Value Share, by Type (2017-2028)

    • Figure Global Human Vaccine Price Trend, by Type (2017-2028)

    • Table China Human Vaccine Sales Volume, by Type (2017-2028)

    • Table China Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure China Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Table China Human Vaccine Sales Value, by Type (2017-2028)

    • Table China Human Vaccine Sales Value Share, by Type (2017-2028)

    • Figure China Human Vaccine Price Trend, by Type (2017-2028)

    • Table Global Human Vaccine Sales Volume, by Application (2017-2028)

    • Table Global Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Global Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Table Global Human Vaccine Sales Value, by Application (2017-2028)

    • Table Global Human Vaccine Sales Value Share, by Application (2017-2028)

    • Figure Global Human Vaccine Sales Value Share, by Application (2017-2028)

    • Table China Human Vaccine Sales Volume, by Application (2017-2028)

    • Table China Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Table China Human Vaccine Sales Value, by Application (2017-2028)

    • Table China Human Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Human Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Human Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure North America Human Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Human Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Human Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Human Vaccine Production, Import, Consumption and Export (2017-2022)

    • Table North America Human Vaccine Sales Volume, by Type (2017-2028)

    • Table North America Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure North America Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Table North America Human Vaccine Sales Volume, by Application (2017-2028)

    • Table North America Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure North America Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure United States Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure United States Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Canada Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Europe Human Vaccine Sales Volume, by Type (2017-2028)

    • Table Europe Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Europe Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Europe Human Vaccine Sales Volume, by Application (2017-2028)

    • Table Europe Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Europe Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Germany Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure UK Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure UK Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure France Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure France Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Italy Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Spain Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Poland Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Russia Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Table APAC Human Vaccine Sales Volume, by Type (2017-2028)

    • Table APAC Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure APAC Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Table APAC Human Vaccine Sales Volume, by Application (2017-2028)

    • Table APAC Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure APAC Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Japan Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure India Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure India Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Human Vaccine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Human Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Human Vaccine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Human Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Human Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Human Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Bharat Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bharat Biotech Product Profiles, Application and Specification

    • Table Bharat Biotech Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bavarian Nordic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bavarian Nordic Product Profiles, Application and Specification

    • Table Bavarian Nordic Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Baxter Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Baxter Product Profiles, Application and Specification

    • Table Baxter Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Human Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.